Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.
Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Burke J, Hua F, Apgar J, Talmor DS, Sauaia A, Liptzin DR, Veress LA, Yaffe MB.
Barrett CD, et al. Among authors: moore ee, moore hb, moore pk.
Res Pract Thromb Haemost. 2020 Jun 12;4(4):524-531. doi: 10.1002/rth2.12357. eCollection 2020 May.
Res Pract Thromb Haemost. 2020.
PMID: 32542213
Free PMC article.
Review.